Small-Molecule Antagonists of Bcl-2 Family Proteins

被引：8

作者：

Brown, Sean P. ^{[1
]}

Taygerly, Joshua P. ^{[1
]}

机构：

[1] Amgen Inc, San Francisco, CA USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47 | 2012年 / 47卷

关键词：

STRUCTURE-BASED DESIGN; X-L; INHIBITOR ABT-263; TARGETING MCL-1; IN-VITRO; DISCOVERY; APOPTOSIS; POTENT; BCL-X(L); POLYPHENOLS;

D O I：

10.1016/B978-0-12-396492-2.00017-5

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：253 / 266

页数：14

共 51 条

[1]

[Anonymous], 2010, The PyMOL Molecular Graphics System, version 1.5, Patent No. [0131000, 131000]

[2]

Attardo G., 2008, Patent No. 7425553

[3] Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review [J].

Bajwa, Naval ;

Liao, Chenzhong ;

Nikolovska-Coleska, Zaneta .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (01) :37-55

[4] Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells [J].

Balakrishnan, Kumudha ;

Wierda, William G. ;

Keating, Michael J. ;

Gandhi, Varsha .

BLOOD, 2008, 112 (05) :1971-1980

[5] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL [J].

Bruncko, Milan ;

Oost, Thorsten K. ;

Belli, Barbara A. ;

Ding, Hong ;

Joseph, Mary K. ;

Kunzer, Aaron ;

Martineau, Darlene ;

McClellan, William J. ;

Mitten, Michael ;

ng, Shi-Chu Ng ;

Nimmer, Paul M. ;

Oltersdorf, Tilman ;

Park, Cheol-Min ;

Petros, Andrew M. ;

Shoemaker, Alexander R. ;

Song, Xiaohong ;

Wang, Xilu ;

Wendt, Michael D. ;

Zhang, Haichao ;

Fesik, Stephen W. ;

Rosenberg, Saul H. ;

Elmore, Steven W. .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) :641-662

[6]

Castro A.C., 2010, Patent, Patent No. [7842815B2, 7842815]

[7] The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo [J].

Chen, Jun ;

Jin, Sha ;

Abraham, Vivek ;

Huang, Xiaoli ;

Liu, Bernard ;

Mitten, Michael J. ;

Nimmer, Paul ;

Lin, Xiaoyu ;

Smith, Morey ;

Shen, Yu ;

Shoemaker, Alexander R. ;

Tahir, Stephen K. ;

Zhang, Haichao ;

Ackler, Scott L. ;

Rosenberg, Saul H. ;

Maecker, Heather ;

Sampath, Deepak ;

Leverson, Joel D. ;

Tse, Chris ;

Elmore, Steven W. .

MOLECULAR CANCER THERAPEUTICS, 2011, 10 (12) :2340-2349

[8] Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity [J].

Dash, Rupesh ;

Azab, Belal ;

Quinn, Bridget A. ;

Shen, Xuening ;

Wang, Xiang-Yang ;

Das, Swadesh K. ;

Rahmani, Mohamed ;

Wei, Jun ;

Hedvat, Michael ;

Dent, Paul ;

Dmitriev, Igor P. ;

Curiel, David T. ;

Grant, Steven ;

Wu, Bainan ;

Stebbins, John L. ;

Pellecchia, Maurizio ;

Reed, John C. ;

Sarkar, Devanand ;

Fisher, Paul B. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (21) :8785-8790

[9] Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL [J].

Degterev, A ;

Lugovskoy, A ;

Cardone, M ;

Mulley, B ;

Wagner, G ;

Mitchison, T ;

Yuan, JY .

NATURE CELL BIOLOGY, 2001, 3 (02) :173-182

[10] Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation [J].

Doi, Kenichiro ;

Li, Rongshi ;

Sung, Shen-Shu ;

Wu, Hongwei ;

Liu, Yan ;

Manieri, Wanda ;

Krishnegowda, Gowdahalli ;

Awwad, Andy ;

Dewey, Alden ;

Liu, Xin ;

Amin, Shantu ;

Cheng, Chunwei ;

Qin, Yong ;

Schonbrunn, Ernst ;

Daughdrill, Gary ;

Loughran, Thomas P., Jr. ;

Sebti, Said ;

Wang, Hong-Gang .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (13) :10224-10235

← 1 2 3 4 5 6 →